ESR1 and triple-negative breast carcinoma: In particular, triple-negative breast cancer (TNBC), which is estrogen receptor (ER)-negative, progesterone receptor (PgR)-negative and human epidermal growth factor receptor 2 (HER2)-negative, has been reported to have higher rates of recurrence and mortality compared to those in other types [2,3].